Bioinformatic and experimental analyses identify GPR84 as a pro-tumorigenic macrophage-associated marker in glioblastoma

Background Tumor-associated macrophages are major contributors to the immunosuppressive microenvironment of glioblastoma (GBM), yet the upstream regulators of their pro-tumorigenic activity remain incompletely defined. Methods Bioinformatic analyses were combined with pharmacological experiments in RAW264.7 macrophages, conditioned-medium assays in GL261 cells, RNA sequencing, protein validation, and an orthotopic glioma model. Results Integrated pan-cancer analyses identified GPR84 as a prognostically adverse gene associated with an inflammatory and macrophage-enriched microenvironment in GBM. In RAW264.7 macrophages, pharmacological GPR84 activation with 6-OAU induced a mixed M2-like immunoregulatory phenotype characterized by increased STAT3 phosphorylation, CD206, TGF-β1, and extracellular IL-10 without altering total STAT3. Stattic partially attenuated STAT3 phosphorylation and CD206 induction, supporting a contributory but incomplete role for STAT3. Conditioned medium from 6-OAU-treated macrophages enhanced GL261 clonogenicity, migration, and invasion. RNA sequencing and protein validation further implicated ECM-receptor interaction and mesenchymal programming in recipient glioma cells. In an orthotopic model, implantation of GL261 cells preconditioned with medium from pharmacologically GPR84-activated macrophages resulted in increased tumor growth and shorter survival in recipient mice. Conclusion These findings support a pharmacological GPR84-STAT3 signaling model in macrophages and identify GPR84 as a candidate pathway for further investigation in glioblastoma.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-11-17
DOI
https://doi.org/10.3389/fimmu.2026.1930625
Primary Topic
Immune cells in cancer
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Bioinformatic and experimental analyses identify GPR84 as a pro-tumorigenic macrophage-associated marker in glioblastoma

XianZhen Chen, Zhouqi Qian, Ran Mo, Zhen Yu et al.
4 links
Frontiers in Immunology
Immune cells in cancer
article

Bioinformatic and experimental analyses identify GPR84 as a pro-tumorigenic macrophage-associated marker in glioblastoma

XianZhen Chen, Zhouqi Qian, Ran Mo, Zhen Yu, Shuyi Lin, Da Tan, Qingyue Yuan, Yuan Zhuang
article en

Abstract

Background Tumor-associated macrophages are major contributors to the immunosuppressive microenvironment of glioblastoma (GBM), yet the upstream regulators of their pro-tumorigenic activity remain incompletely defined. Methods Bioinformatic analyses were combined with pharmacological experiments in RAW264.7 macrophages, conditioned-medium assays in GL261 cells, RNA sequencing, protein validation, and an orthotopic glioma model. Results Integrated pan-cancer analyses identified GPR84 as a prognostically adverse gene associated with an inflammatory and macrophage-enriched microenvironment in GBM. In RAW264.7 macrophages, pharmacological GPR84 activation with 6-OAU induced a mixed M2-like immunoregulatory phenotype characterized by increased STAT3 phosphorylation, CD206, TGF-β1, and extracellular IL-10 without altering total STAT3. Stattic partially attenuated STAT3 phosphorylation and CD206 induction, supporting a contributory but incomplete role for STAT3. Conditioned medium from 6-OAU-treated macrophages enhanced GL261 clonogenicity, migration, and invasion. RNA sequencing and protein validation further implicated ECM-receptor interaction and mesenchymal programming in recipient glioma cells. In an orthotopic model, implantation of GL261 cells preconditioned with medium from pharmacologically GPR84-activated macrophages resulted in increased tumor growth and shorter survival in recipient mice. Conclusion These findings support a pharmacological GPR84-STAT3 signaling model in macrophages and identify GPR84 as a candidate pathway for further investigation in glioblastoma.

Frontiers in ImmunologyVol. 17
Tongji University (CN), Wenzhou Medical University (CN), Shanghai Tenth People's Hospital (CN), Nanjing Medical University (CN)
Good health and well-being
Immune cells in cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon